BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Anika Therapeutics Inc. (ANIK) on Wednesday reported a loss of $21.9 million in its fourth quarter.
On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of $1.50. Losses, adjusted to account for discontinued operations and stock option expense, were 3 cents per share.
The medical technology company posted revenue of $30.6 million in the period.
For the year, the company reported that its loss narrowed to $56.4 million, or $3.83 per share. Revenue was reported as $119.9 million.
Anika shares have risen roughly 4% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $17.09, a fall of 34% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANIK at https://www.zacks.com/ap/ANIK
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
